PortfoliosLab logoPortfoliosLab logo
ADI vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ADI vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Analog Devices, Inc. (ADI) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ADI achieves a 53.24% return, which is significantly higher than ABBV's 4.49% return. Over the past 10 years, ADI has outperformed ABBV with an annualized return of 24.66%, while ABBV has yielded a comparatively lower 19.47% annualized return.


ADI

1D
1.45%
1M
4.34%
YTD
53.24%
6M
49.73%
1Y
78.19%
3Y*
32.62%
5Y*
21.81%
10Y*
24.66%

ABBV

1D
0.06%
1M
8.90%
YTD
4.49%
6M
3.85%
1Y
30.72%
3Y*
24.38%
5Y*
20.19%
10Y*
19.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ADI vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ADI
Analog Devices, Inc.
53.24%29.75%8.82%23.36%-4.91%20.96%26.87%41.31%-1.64%25.30%
ABBV
AbbVie Inc.
4.49%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between ADI and ABBV is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.25

Over the past year, the correlation between ADI and ABBV has dropped to 0.01 - well below their long-term average of 0.25, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

ADI:

$202.64B

ABBV:

$416.69B

EPS

ADI:

$6.72

ABBV:

$2.05

PE Ratio

ADI:

61.48

ABBV:

114.44

PS Ratio

ADI:

15.99

ABBV:

6.63

PB Ratio

ADI:

6.01

ABBV:

15.15

Total Revenue (TTM)

ADI:

$12.74B

ABBV:

$62.82B

Gross Profit (TTM)

ADI:

$8.22B

ABBV:

$46.15B

EBITDA (TTM)

ADI:

$6.19B

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ADI vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADI
ADI Risk / Return Rank: 9191
Overall Rank
ADI Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
ADI Sortino Ratio Rank: 9090
Sortino Ratio Rank
ADI Omega Ratio Rank: 8989
Omega Ratio Rank
ADI Calmar Ratio Rank: 9292
Calmar Ratio Rank
ADI Martin Ratio Rank: 9292
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 7474
Overall Rank
ABBV Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 7474
Sortino Ratio Rank
ABBV Omega Ratio Rank: 7373
Omega Ratio Rank
ABBV Calmar Ratio Rank: 7474
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADI vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Analog Devices, Inc. (ADI) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ADIABBVDifference
Sharpe ratioReturn per unit of total volatility

+1.13

Sortino ratioReturn per unit of downside risk

+1.18

Omega ratioGain probability vs. loss probability

1.39

1.23

+0.16

Calmar ratioReturn relative to maximum drawdown

5.00

1.78

+3.22

Martin ratioReturn relative to average drawdown

13.63

3.96

+9.67

ADI vs. ABBV - Sharpe Ratio Comparison

The current ADI Sharpe Ratio is 2.35, which is higher than the ABBV Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of ADI and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ADI vs. ABBV - Drawdown Comparison

The maximum ADI drawdown since its inception was -82.88%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ADI and ABBV.


Loading charts...

Drawdown Indicators


ADIABBVDifference

Max Drawdown

Largest peak-to-trough decline

-82.88%

-45.09%

-37.79%

Max Drawdown (1Y)

Largest decline over 1 year

-15.73%

-17.32%

+1.59%

Max Drawdown (3Y)

Largest decline over 3 years

-32.20%

-20.74%

-11.46%

Max Drawdown (5Y)

Largest decline over 5 years

-32.20%

-21.92%

-10.28%

Max Drawdown (10Y)

Largest decline over 10 years

-33.62%

-45.09%

+11.47%

Current Drawdown

Current decline from peak

-7.26%

-1.60%

-5.66%

Average Drawdown

Average peak-to-trough decline

-33.89%

-10.70%

-23.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.76%

7.78%

-2.02%

Volatility

ADI vs. ABBV - Volatility Comparison

Analog Devices, Inc. (ADI) has a higher volatility of 17.32% compared to AbbVie Inc. (ABBV) at 9.26%. This indicates that ADI's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ADIABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.32%

9.26%

+8.06%

Volatility (6M)

Calculated over the trailing 6-month period

27.42%

19.03%

+8.39%

Volatility (1Y)

Calculated over the trailing 1-year period

33.44%

25.22%

+8.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.47%

23.12%

+10.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.92%

25.82%

+7.10%

Dividends

ADI vs. ABBV - Dividend Comparison

ADI's dividend yield for the trailing twelve months is around 1.01%, less than ABBV's 2.87% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.87%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
ADI
Analog Devices, Inc.
1.01%1.46%1.73%1.73%1.85%1.57%1.68%1.82%2.24%2.02%2.31%2.89%

Financials

ADI vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Analog Devices, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
3.62B
15.00B
(ADI) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

ADI vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Analog Devices, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%80.0%85.0%20222023202420252026
67.3%
83.5%
Portfolio components
ADI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a gross profit of 2.44B and revenue of 3.62B. Therefore, the gross margin over that period was 67.3%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

ADI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported an operating income of 1.38B and revenue of 3.62B, resulting in an operating margin of 38.1%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

ADI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Analog Devices, Inc. reported a net income of 1.18B and revenue of 3.62B, resulting in a net margin of 32.5%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


ADI and ABBV have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ADI has higher volatility (17.32%) compared to ABBV (9.26%). In terms of maximum drawdown, ADI dropped -82.88% vs ABBV's -45.09%.

ADI currently has the higher Sharpe Ratio (2.35 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ADI and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer